The British Medical Association (BMA) has warned the UK government that patients are concerned about the misuse of their personal information by the NHS Federated Data Platform (FDP), especially if the contract is awarded to US technology company Palantir. The creation of the FDP has raised concerns about privacy and trust in the NHS, with patients potentially refusing to share their data due to suspicion surrounding it. In a letter to the Secretary of State for Health and Social Care, Steve Barclay, the BMA has expressed "serious concerns" about the FDP, including an alleged lack of public consultation and vetting of bidders on "ethical" grounds, which may encourage patients to avoid it. The BMA's chair, Dr Latifa Patel, stated that the FDP could end up facing the same lack of support that caused the NHS's last two attempts to bring patient data together to fail. There is a need for a full and proper public consultation to establish the scope and scale of the program and to assure patients that their confidential data won't be used for commercial gain, according to Patel.
What is this page?
You are reading a summary article on the Privacy Newsfeed, a free resource for DPOs and other professionals with privacy or data protection responsibilities helping them stay informed of industry news all in one place. The information here is a brief snippet relating to a single piece of original content or several articles about a common topic or thread. The main contributor is listed in the top left-hand corner, just beneath the article title.
The Privacy Newsfeed monitors over 300 global publications, of which more than 4,350 summary articles have been posted to the online archive dating back to the beginning of 2020. A weekly roundup is available by email every Friday.